PET and PET-CT of Lung Cancer

Methods in Molecular Biology

Volumn 727, Issue , 2011, Pages 33-51

  Steinert, Hans C ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Computed tomography; Image fusion; Lung cancer; Positron emission tomography; Staging

Indexed keywords

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ARTICLE; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HUMAN; LUNG; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG TUMOR; METHODOLOGY; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING; TUMOR RECURRENCE;

CARCINOMA, NON-SMALL-CELL LUNG; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG; LUNG NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SMALL CELL LUNG CARCINOMA; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 79956331278     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-062-1_3     Document Type: Chapter

References (38)

1. Lardinois, D., Weder, W., Hany, T.F., et al. (2003) Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 348, 2500–7.
2. Antoch, G., Stattaus, J., Nemat, A.T., et al. (2003) Non small cell lung cancer: dualmodality PET-CT in preoperative staging. Radiology 229, 526–33.
3. Sung, S.S., Kyung, S.L., Byung-Tae, K., et al. (2005) Non-small cell lung cancer: prospective comparison of integrated FDG PET-CT and CT alone for preoperative staging. Radiology 236, 1011–19.
4. Mountain, C.F. (2000) The international system for staging lung cancer. Semin Surg Oncol 18, 106–15.
5. Rami-Porta, R., Crowley, J.J., Goldstraw, P. (2009) The revised TNM staging system for lung cancer. Ann Thorac Cardivasc Surg 15, 4–9.
6. Goldstraw, P., Crowley, J.J., Chansky, K., et al. (2007) The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumors. J Thorac Oncol 2, 706–14.
7. Patz, E.F., Lowe, J.M., Hoffmann, J.M., et al. (1993) Focal pulmonary abnormalities: Evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 188, 487–90.
8. Gupta, N.C., Maloof, J., Gunel, E. (1996) Probability of malignancy in solitary pulmonary nodules using flurine-18-FDF and PET. J Nucl Med 37, 943–8.
9. Higashi, K., Ueda, Y., Seki, H., et al. (1998) Fluorine-18-FDG imaging is negative in bronchioloalveolar lung carcinoma. J Nucl Med 39, 1016–20.
10. Erasmus, J.J., McAdams, H.P., Patz, E.F., Coleman, R.E., Ahuma, V., Goodman, P.C. (1998) Evaluation of primary pulmonary carcinoid tumors using positron emission tomography with 18F-fluorodeoxyglucose. AJR Am J Roentgenol 170, 1369–73.
11. Webb, W.R., Gatsonis, C., Zerhouni, E., et al. (1991) CT and MR imaging in staging nonsmall cell bronchogenic carcinoma: Report of the Radiology Diagnostic Oncology Group. Radiology 178, 705–13.
12. Rendina, E.A., Bognolo, D.A., Mineo, T.C., et al. (1987) Computer tomography for the evaluation of intrathoracic invasion by lung cancer. J Thorac Cardiovasc Surg 94, 57–63.
13. Toloza, E., Harpole, L., McCrory, D.C. (2003) Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest (suppl), 137s–46s.
14. Steinert, H.C., Hauser, M., Allemann, F., et al. (1997) Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology 202, 441–6.
15. Vansteenkiste, J.F., Stroobants, S.G., De Leyn, P.R., et al. (1998) Lymph node staging in nonsmall cell lung cancer with FDG PET scan: a prospective study on 690 lymph node stations from 68 patients. J Clin Oncol 16, 2142–9.
16. Pieterman, R.M., van Putten, J.W.G., Meuzelaar, J.J., et al. (2000) Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 343, 254–61.
17. Gould, M.K., Kuschner, W.G., Rydzak, C.E., et al. (2003) Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small lung cancer: a meta-analysis. Ann Intern Med 139, 879–92.
18. Patterson, G.A., Ginsberg, R.J., Poon, P.Y., et al. (1987) A prospective evaluation of magnetic resonance imaging, computed tomography, and mediastinoscopy in the preoperative assessment of mediastinal node status in bronchogenic carcinoma. J Thorac Cardiovasc Surg 94, 679–84.
19. Kernstine, K.H., McLaughlin, K.A., Menda, Y., et al. (2002) Can-FDG PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer. Ann Thorac Surg 73, 394–402.
20. Weder, W., Schmid, R., Bruchhaus, H., Hillinger, S., von Schulthess, G.K., Steinert, H.C. (1998) Detection of extrathoracic metastases by positron emission tomography in lung cancer. Ann Thorac Surg 66, 886–93.
21. Hellwig, D., Ukena, D., Paulsen, F., Bamberg, M., Kirsch, C.M. (2001) Metaanalyse zum Stellenwert der Positronen-EmissionsTomographie mit F-18-Fluorodesoxyglucose (FDG-PET) bei Lungentumoren. Pneumologie 55, 367–77.
22. Lamki, L.M. (1997) Positron emission tomography, bronchogenic carcinoma, and the adrenals. AJR Am J Roentgenol 168, 1361–2.
23. Erasmus, J.J., Patz, E.F., McAdams, H.P., et al. (1997) Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol 168, 1357–62.
24. Marom, E.M., McAdams, H.P., Erasmus, J.J. (1999) Staging non-small cell lung cancer with whole-body PET. Radiology 212, 803–9.
25. Akhurst, T., Downey, R.J., Ginsberg, M.S., et al. (2002) An initial experience with FDGPET in the imaging of residual disease after induction therapy for lung cancer. Ann Thorac Surg 73, 259–66.
26. Strauss, L.G. (1996) Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnosis of oncological patients. Eur J Nucl Med 23, 1409–14.
27. Kamel, E.M., McKee, T.A., Calcagni, M.L., et al. (2005) Occult lung infarction may induce false interpretation of F-18 FDG PET in primary staging of pulmonary malignancies. Eur J Nucl Med Mol Imaging 32, 641–6.
28. Kamel, E., Goerres, G.W., Burger, C., von Schulthess, G.K., Steinert, H.C. (2002) Detection of recurrent laryngeal nerve palsy in patients with lung cancer using PET-CT image fusion. Radiology 224, 153–6.
29. Lardinois, D., Weder, W., Roudas, M., et al. (2005) Etiology of solitary extrapulmonary positron emission tomography and computed tomography findings in patients with lung cancer. J Clin Oncol 23, 6846–53.
30. Inoue, T., Kim, E., Komaki, R., et al. (1995) Detecting recurrent or residual lung cancer with FDG-PET. J Nucl Med 36, 788–93.
31. Hicks, R.J., Kalff, V., MacManus, M.P., et al. (2001) The utility of F-18 FDG PET for suspected recurrent non-small cell lung cancer after potentially curative therapy: impact on management and prognostic stratification. J Nucl Med 42, 1605–13.
32. Keidar, Z., Haim, N., Guralnik, L., et al. (2004) PET-CT using F-18 FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management. J Nucl Med 45, 1640–6.
33. Weber, W.A., Peterson, V., Schmidt, B., et al. (2003) Positron emission tomography in nonsmall cell lung cancer: prediction of response to chemotherapy by quantitative assessment to glucose use. J Clin Oncol 21, 2651–7.
34. MacManus, M.P., Hicks, R.J., Matthews, J.P., et al. (2003) Positron emission tomography is superior to computed tomography for response-assessment after radical radiotherapy or chemoradiotherapy in patients with nonsmall cell lung cancer. J Clin Oncol 21, 1285–92.
35. Gambhir, S.S., Hoh, C.K., Phelps, M.E., Madar, I., Maddahi, J. (1996) Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma. J Nucl Med 37, 1428–36.
36. Scott, W.J., Shepherd, J., Gambhir, S.S. (1998) Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: a decision analysis. Ann Thorac Surg 66, 1876–85.
37. Dietlein, M., Weber, K., Gandjour, A., et al. (2000) Cost-effectiveness of FDG-PET for the management of potentially operable nonsmall cell lung cancer: priority for a PET-based strategy after nodal-negative CT results. Eur J Nucl Med 27, 1598–609.
38. Van Tinteren, H., Hoekstra, O.S., van den Bergh, J.H., et al. (2002) Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet 359, 1388–92.